US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Beyondspring Inc

1.49

-0.0302-1.99%

Post-market: 1.490.00000.00%19:38 EDT

Volume:9.89K

Turnover:15.23K

Market Cap:61.27M

PE:-59.85

High:1.66

Open:1.59

Low:1.46

Close:1.52

52wk High:3.44

52wk Low:1.21

Shares:41.12M

Float Shares:30.22M

Volume Ratio:1.38

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0249

EPS(LYR):-0.0249

ROE:-310.48%

ROA:-18.56%

PB:-1.91

PE(LYR):-59.85

Loading ...

Overview Company News Filings

BeyondSpring publishes corporate presentation on plinabulin immune-modulating cancer therapy pipeline

BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs

BeyondSpring to present plinabulin-ADC combination data at AACR annual meeting poster session

BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026

BeyondSpring publishes IO360 Summit presentation on plinabulin; PD-1/L1 resistance highlighted

BeyondSpring publishes corporate presentation; plinabulin clinical program advances and SEED targeted protein degradation pipeline grows

BeyondSpring FY2025 net loss drops 15% to $14 million; research and development expenses climb 66% to $4 million

BeyondSpring Files 2025 Annual Report on Form 10-K

BeyondSpring Q4 EPS $(0.05)

BeyondSpring FY2025 operating loss narrows 2.25% to $8.7 million; R&D expenses jump 69.23% to $4.4 million

Beyondspring Reports 2025 Year-End Financial Results

THOMSON REUTERS

Press Release: BeyondSpring Reports 2025 Year-End Financial Results

BeyondSpring Showcases Plinabulin at Immuno-Oncology 360° Conference

BeyondSpring Sells $35.4 Million Stake in SEED Therapeutics to Strategic Investors

BeyondSpring Shares Shares Jump Premarket Following Positive Trial Results

BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path

BeyondSpring Reports Plinabulin Plus Docetaxel Improves Survival in EGFR Wild-Type NSCLC After Checkpoint Inhibitor Failure

Beyondspring Announces New Analyses of Dublin-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-Pd-(L)1 for Non-Squamous Egfr Wt Nsclc and a Reduction in Brain Metastasis Compared to Docetaxel at Naclc 2025

THOMSON REUTERS

BeyondSpring Q3 EPS $(0.04) Up From $(0.05) YoY

Drugmaker BeyondSpring's Q3 net loss narrows to $1.7 mln

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BYSI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BYSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BYSI\",,,,,undefined,":{"symbol":"BYSI","market":"US","secType":"STK","nameCN":"Beyondspring Inc","latestPrice":1.49,"timestamp":1777665600000,"preClose":1.5202,"halted":0,"volume":9894,"hourTrading":{"tag":"盘后","latestPrice":1.49,"preClose":1.49,"latestTime":"19:38 EDT","volume":14,"amount":21.7,"timestamp":1777678704284,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01986580713064071,"floatShares":30219373,"shares":41122299,"eps":-0.024897,"marketStatus":"Market Closed","change":-0.0302,"latestTime":"05-01 16:00:00 EDT","open":1.59,"high":1.66,"low":1.46,"amount":15232.359148799998,"amplitude":0.131562,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.024897,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1489035600000,"exchange":"NASDAQ","adjPreClose":1.5202,"preHourTrading":{"tag":"盘前","latestPrice":1.52,"preClose":1.61,"latestTime":"04:00 EDT","volume":100,"amount":152,"timestamp":1777622413054,"change":-0.09,"changeRate":-0.055901,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.49,"preClose":1.49,"latestTime":"19:38 EDT","volume":14,"amount":21.7,"timestamp":1777678704284,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3839485110303786,"impliedVol":0.4474,"impliedVolPercentile":0.6255},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BYSI\",,,,,undefined,":{"symbol":"BYSI","floatShares":30219373,"roa":"-18.56%","roe":"-310.48%","lyrEps":-0.024897,"volumeRatio":1.3839485110303786,"shares":41122299,"dividePrice":0,"high":1.66,"amplitude":0.131562,"preClose":1.5202,"low":1.46,"week52Low":1.21,"pbRate":"-1.91","psRate":"32.66","week52High":3.44,"institutionHeld":0,"latestPrice":1.49,"eps":-0.024897,"divideRate":0,"volume":9894,"delay":0,"ttmEps":-0.024897,"open":1.59,"prevYearClose":1.63,"prevWeekClose":1.705,"prevMonthClose":1.5202,"prevQuarterClose":1.64,"fiveDayClose":1.705,"twentyDayClose":1.725,"sixtyDayClose":1.57},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BYSI\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BYSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774425600000,"name":null,"time":"Pre-Market","dateTimestamp":1774411200000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"BYSI","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-08-13","symbol":"BYSI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.04},{"market":"US","date":"2025-05-12","symbol":"BYSI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.06},{"date":"2025-03-27","symbol":"BYSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"Pre-Market","dateTimestamp":1743048000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BYSI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BYSI\",market:\"US\",delay:true,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BYSI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"BYSI","date":"2026-05-01","current":-59.846568,"percent":0.113782,"low":-161.60109,"twenty":-17.553263,"median":-4.014996,"eighty":-1.061383,"high":-0.342396,"avg":-16.936375,"sd":32.245698,"marketCap":62510350},"quantilePoints":[{"date":"2021-05-07","current":-6.400805,"twenty":-11.15548,"median":-8.824979,"eighty":-7.380125,"marketCap":390276273},{"date":"2021-05-14","current":-6.253291,"twenty":-11.148807,"median":-8.82138,"eighty":-7.378593,"marketCap":381281930},{"date":"2021-05-21","current":-6.869,"twenty":-11.125249,"median":-8.81811,"eighty":-7.362384,"marketCap":418823535},{"date":"2021-05-28","current":-6.650936,"twenty":-11.106282,"median":-8.805919,"eighty":-7.357136,"marketCap":405527550},{"date":"2021-06-04","current":-6.862586,"twenty":-11.102292,"median":-8.799496,"eighty":-7.345234,"marketCap":418432477},{"date":"2021-06-11","current":-7.330781,"twenty":-11.090084,"median":-8.787195,"eighty":-7.342001,"marketCap":446979739},{"date":"2021-06-18","current":-7.3818,"twenty":-11.062511,"median":-8.775305,"eighty":-7.342001,"marketCap":456763639},{"date":"2021-06-25","current":-6.768757,"twenty":-11.029242,"median":-8.769533,"eighty":-7.341424,"marketCap":418830357},{"date":"2021-07-02","current":-6.673956,"twenty":-11.005487,"median":-8.748166,"eighty":-7.335484,"marketCap":412964386},{"date":"2021-07-09","current":-6.617076,"twenty":-11.004497,"median":-8.741088,"eighty":-7.303883,"marketCap":409444803},{"date":"2021-07-16","current":-6.256834,"twenty":-10.998539,"median":-8.734483,"eighty":-7.284662,"marketCap":387154112},{"date":"2021-07-23","current":-6.162033,"twenty":-10.983171,"median":-8.727727,"eighty":-7.276869,"marketCap":381288141},{"date":"2021-07-30","current":-6.016673,"twenty":-10.963416,"median":-8.716203,"eighty":-7.257672,"marketCap":372293651},{"date":"2021-08-06","current":-16.981932,"twenty":-10.998539,"median":-8.717818,"eighty":-7.246608,"marketCap":1050791010},{"date":"2021-08-13","current":-13.714474,"twenty":-11.068347,"median":-8.729356,"eighty":-7.257672,"marketCap":848610529},{"date":"2021-08-20","current":-12.760149,"twenty":-11.13984,"median":-8.73454,"eighty":-7.262914,"marketCap":789559750},{"date":"2021-08-27","current":-18.201699,"twenty":-11.28959,"median":-8.741221,"eighty":-7.263701,"marketCap":1126266508},{"date":"2021-09-03","current":-16.962972,"twenty":-11.306172,"median":-8.751794,"eighty":-7.267265,"marketCap":1049617815},{"date":"2021-09-10","current":-13.969717,"twenty":-11.349009,"median":-8.774324,"eighty":-7.276775,"marketCap":955975683},{"date":"2021-09-17","current":-13.095181,"twenty":-11.577555,"median":-8.780006,"eighty":-7.277247,"marketCap":896129415},{"date":"2021-09-24","current":-8.81967,"twenty":-11.511898,"median":-8.779659,"eighty":-7.279472,"marketCap":603547659},{"date":"2021-10-01","current":-8.796806,"twenty":-11.414906,"median":-8.784917,"eighty":-7.280852,"marketCap":601983051},{"date":"2021-10-08","current":-8.551022,"twenty":-11.373288,"median":-8.775305,"eighty":-7.283325,"marketCap":585163511},{"date":"2021-10-15","current":-9.459853,"twenty":-11.349009,"median":-8.782183,"eighty":-7.290009,"marketCap":647356692},{"date":"2021-10-22","current":-9.139762,"twenty":-11.329516,"median":-8.789263,"eighty":-7.2923,"marketCap":625452175},{"date":"2021-10-29","current":-7.899406,"twenty":-11.307631,"median":-8.784917,"eighty":-7.297158,"marketCap":540572174},{"date":"2021-11-05","current":-8.676772,"twenty":-11.307631,"median":-8.784707,"eighty":-7.297158,"marketCap":593768857},{"date":"2021-11-12","current":-8.459567,"twenty":-11.300335,"median":-8.777482,"eighty":-7.330781,"marketCap":578905078},{"date":"2021-11-19","current":-7.573599,"twenty":-11.300335,"median":-8.774324,"eighty":-7.333884,"marketCap":518276506},{"date":"2021-11-26","current":-8.20235,"twenty":-11.294499,"median":-8.764743,"eighty":-7.333263,"marketCap":561303234},{"date":"2021-12-03","current":-2.297801,"twenty":-11.29304,"median":-8.74476,"eighty":-7.297158,"marketCap":157243136},{"date":"2021-12-10","current":-2.389256,"twenty":-11.279239,"median":-8.735735,"eighty":-7.28283,"marketCap":163501569},{"date":"2021-12-17","current":-2.617893,"twenty":-11.184539,"median":-8.732706,"eighty":-7.274397,"marketCap":179147652},{"date":"2021-12-23","current":-2.812234,"twenty":-11.15548,"median":-8.724843,"eighty":-7.260231,"marketCap":192446823},{"date":"2021-12-31","current":-2.453771,"twenty":-11.148807,"median":-8.714589,"eighty":-7.243476,"marketCap":177314406},{"date":"2022-01-07","current":-2.453771,"twenty":-11.125249,"median":-8.713986,"eighty":-7.235633,"marketCap":177314406},{"date":"2022-01-14","current":-2.101685,"twenty":-11.106282,"median":-8.69392,"eighty":-7.22882,"marketCap":151871941},{"date":"2022-01-21","current":-1.776682,"twenty":-11.102292,"median":-8.693667,"eighty":-7.22195,"marketCap":128386589},{"date":"2022-01-28","current":-1.630431,"twenty":-11.090084,"median":-8.682709,"eighty":-7.20706,"marketCap":117818181},{"date":"2022-02-04","current":-1.662931,"twenty":-11.062511,"median":-8.676855,"eighty":-7.172414,"marketCap":120166716},{"date":"2022-02-11","current":-1.608764,"twenty":-11.029242,"median":-8.675168,"eighty":-7.155129,"marketCap":116252491},{"date":"2022-02-18","current":-1.435429,"twenty":-11.005487,"median":-8.659624,"eighty":-7.143917,"marketCap":103726970},{"date":"2022-02-25","current":-1.365012,"twenty":-11.004497,"median":-8.641816,"eighty":-7.109794,"marketCap":98638477},{"date":"2022-03-04","current":-1.077926,"twenty":-10.998539,"median":-8.624931,"eighty":-7.072868,"marketCap":77893083},{"date":"2022-03-11","current":-1.007509,"twenty":-10.983171,"median":-8.613897,"eighty":-7.046745,"marketCap":72804590},{"date":"2022-03-18","current":-1.251261,"twenty":-10.963416,"median":-8.59976,"eighty":-6.999757,"marketCap":90418604},{"date":"2022-03-25","current":-1.20251,"twenty":-10.956482,"median":-8.596563,"eighty":-6.97543,"marketCap":86895801},{"date":"2022-04-01","current":-1.300011,"twenty":-10.947277,"median":-8.592937,"eighty":-6.930407,"marketCap":93941407},{"date":"2022-04-08","current":-1.283761,"twenty":-10.934968,"median":-8.577836,"eighty":-6.887865,"marketCap":92767139},{"date":"2022-04-14","current":-1.328337,"twenty":-10.931928,"median":-8.571023,"eighty":-6.881827,"marketCap":85251362},{"date":"2022-04-22","current":-1.182766,"twenty":-10.874867,"median":-8.55388,"eighty":-6.862586,"marketCap":75908747},{"date":"2022-04-29","current":-0.921951,"twenty":-10.869132,"median":-8.543875,"eighty":-6.844639,"marketCap":59169895},{"date":"2022-05-06","current":-0.97654,"twenty":-10.799881,"median":-8.518237,"eighty":-6.824288,"marketCap":62673376},{"date":"2022-05-13","current":-0.758183,"twenty":-10.793266,"median":-8.475943,"eighty":-6.802132,"marketCap":48659453},{"date":"2022-05-20","current":-0.782445,"twenty":-10.757701,"median":-8.440174,"eighty":-6.794418,"marketCap":50216556},{"date":"2022-05-27","current":-0.800642,"twenty":-10.666331,"median":-8.417431,"eighty":-6.777322,"marketCap":51384383},{"date":"2022-06-03","current":-0.964409,"twenty":-10.593851,"median":-8.40388,"eighty":-6.766317,"marketCap":61894825},{"date":"2022-06-10","current":-1.073588,"twenty":-10.535211,"median":-8.379544,"eighty":-6.743515,"marketCap":68901786},{"date":"2022-06-17","current":-0.8431,"twenty":-10.485959,"median":-8.340934,"eighty":-6.72321,"marketCap":54109312},{"date":"2022-06-24","current":-0.8431,"twenty":-10.428365,"median":-8.316315,"eighty":-6.693158,"marketCap":54109312},{"date":"2022-07-01","current":-0.946213,"twenty":-10.400502,"median":-8.301716,"eighty":-6.672201,"marketCap":60726998},{"date":"2022-07-08","current":-1.09785,"twenty":-10.388718,"median":-8.29285,"eighty":-6.654109,"marketCap":70458889},{"date":"2022-07-15","current":-0.970475,"twenty":-10.36542,"median":-8.27886,"eighty":-6.644132,"marketCap":62284100},{"date":"2022-07-22","current":-0.8431,"twenty":-10.301418,"median":-8.238859,"eighty":-6.618151,"marketCap":54109312},{"date":"2022-07-29","current":-0.8431,"twenty":-10.252094,"median":-8.216736,"eighty":-6.607281,"marketCap":54109312},{"date":"2022-08-05","current":-0.915886,"twenty":-10.210516,"median":-8.20235,"eighty":-6.590159,"marketCap":58780620},{"date":"2022-08-12","current":-0.964409,"twenty":-10.173794,"median":-8.18979,"eighty":-6.556471,"marketCap":61894825},{"date":"2022-08-19","current":-0.946213,"twenty":-10.154544,"median":-8.161715,"eighty":-6.517533,"marketCap":60726998},{"date":"2022-08-26","current":-0.806707,"twenty":-10.091811,"median":-8.14509,"eighty":-6.480049,"marketCap":51773658},{"date":"2022-09-02","current":-0.770314,"twenty":-10.001482,"median":-8.100262,"eighty":-6.450482,"marketCap":49438005},{"date":"2022-09-09","current":-0.940147,"twenty":-9.993794,"median":-8.075287,"eighty":-6.419817,"marketCap":60337722},{"date":"2022-09-16","current":-0.830969,"twenty":-9.971244,"median":-8.054429,"eighty":-6.391117,"marketCap":53330761},{"date":"2022-09-23","current":-0.64294,"twenty":-9.950155,"median":-8.021655,"eighty":-6.338172,"marketCap":41263216},{"date":"2022-09-30","current":-0.600481,"twenty":-9.913473,"median":-8.015173,"eighty":-6.301074,"marketCap":38538287},{"date":"2022-10-07","current":-0.590595,"twenty":-9.889115,"median":-7.97709,"eighty":-6.254861,"marketCap":37903768},{"date":"2022-10-14","current":-0.521812,"twenty":-9.850961,"median":-7.945258,"eighty":-6.207183,"marketCap":33489382},{"date":"2022-10-21","current":-0.491849,"twenty":-9.81876,"median":-7.926159,"eighty":-6.166303,"marketCap":31566360},{"date":"2022-10-28","current":-0.485237,"twenty":-9.793262,"median":-7.900693,"eighty":-6.152974,"marketCap":31142050},{"date":"2022-11-04","current":-0.441141,"twenty":-9.758343,"median":-7.867886,"eighty":-6.122096,"marketCap":28312016},{"date":"2022-11-11","current":-0.424583,"twenty":-9.733956,"median":-7.829624,"eighty":-6.083665,"marketCap":27249294},{"date":"2022-11-18","current":-0.387401,"twenty":-9.705595,"median":-7.81793,"eighty":-5.903749,"marketCap":24863034},{"date":"2022-11-25","current":-0.361684,"twenty":-9.686755,"median":-7.810813,"eighty":-5.7831,"marketCap":23212505},{"date":"2022-12-02","current":-0.347127,"twenty":-9.682822,"median":-7.771856,"eighty":-2.793943,"marketCap":22278244},{"date":"2022-12-09","current":-0.369994,"twenty":-9.682822,"median":-7.746125,"eighty":-2.621323,"marketCap":23745813},{"date":"2022-12-16","current":-1.382927,"twenty":-9.682822,"median":-7.73971,"eighty":-2.570308,"marketCap":88754843},{"date":"2022-12-23","current":-1.025064,"twenty":-9.677099,"median":-7.719207,"eighty":-2.463076,"marketCap":65787581},{"date":"2022-12-30","current":-1.140308,"twenty":-9.677099,"median":-7.706017,"eighty":-2.431933,"marketCap":73183818},{"date":"2023-01-06","current":-1.055391,"twenty":-9.677099,"median":-7.684438,"eighty":-2.36321,"marketCap":67733959},{"date":"2023-01-13","current":-1.29801,"twenty":-9.677099,"median":-7.671666,"eighty":-2.219355,"marketCap":83304984},{"date":"2023-01-20","current":-1.516367,"twenty":-9.677099,"median":-7.671666,"eighty":-1.914266,"marketCap":97318907},{"date":"2023-01-27","current":-1.534563,"twenty":-9.670972,"median":-7.643672,"eighty":-1.765848,"marketCap":98486734},{"date":"2023-02-03","current":-1.637676,"twenty":-9.670972,"median":-7.624089,"eighty":-1.683515,"marketCap":105104420},{"date":"2023-02-10","current":-1.352599,"twenty":-9.670972,"median":-7.620572,"eighty":-1.662931,"marketCap":86808465},{"date":"2023-02-17","current":-1.23129,"twenty":-9.670972,"median":-7.620572,"eighty":-1.623166,"marketCap":79022952},{"date":"2023-02-24","current":-1.152439,"twenty":-9.670972,"median":-7.620572,"eighty":-1.606597,"marketCap":73962369},{"date":"2023-03-03","current":-1.570917,"twenty":-9.670972,"median":-7.620572,"eighty":-1.580661,"marketCap":72846553},{"date":"2023-03-10","current":-1.201289,"twenty":-9.670972,"median":-7.610609,"eighty":-1.558614,"marketCap":55706187},{"date":"2023-03-17","current":-1.041677,"twenty":-9.670972,"median":-7.590746,"eighty":-1.531324,"marketCap":48304666},{"date":"2023-03-24","current":-0.898867,"twenty":-9.670972,"median":-7.586599,"eighty":-1.45222,"marketCap":41682252},{"date":"2023-03-31","current":-0.94087,"twenty":-9.669751,"median":-7.58433,"eighty":-1.382927,"marketCap":43630021},{"date":"2023-04-06","current":-0.890466,"twenty":-9.669751,"median":-7.582522,"eighty":-1.36419,"marketCap":41292698},{"date":"2023-04-14","current":-1.008075,"twenty":-9.670972,"median":-7.582522,"eighty":-1.323507,"marketCap":46746451},{"date":"2023-04-21","current":-1.253931,"twenty":-9.670972,"median":-7.582522,"eighty":-1.308256,"marketCap":41729568},{"date":"2023-04-28","current":-1.125022,"twenty":-9.670972,"median":-7.570231,"eighty":-1.293534,"marketCap":37439613},{"date":"2023-05-05","current":-1.054708,"twenty":-9.670972,"median":-7.56517,"eighty":-1.262094,"marketCap":35099637},{"date":"2023-05-12","current":-1.183617,"twenty":-9.670972,"median":-7.56517,"eighty":-1.252863,"marketCap":39389592},{"date":"2023-05-19","current":-1.207055,"twenty":-9.670972,"median":-7.56517,"eighty":-1.240995,"marketCap":40169584},{"date":"2023-05-26","current":-1.218774,"twenty":-9.670972,"median":-7.56447,"eighty":-1.236417,"marketCap":40559580},{"date":"2023-06-02","current":-1.26565,"twenty":-9.670972,"median":-7.56447,"eighty":-1.228445,"marketCap":42119564},{"date":"2023-06-09","current":-1.417997,"twenty":-9.670972,"median":-7.56447,"eighty":-1.228445,"marketCap":47189512},{"date":"2023-06-16","current":-1.406278,"twenty":-9.670972,"median":-7.56447,"eighty":-1.228445,"marketCap":46799516},{"date":"2023-06-23","current":-1.406278,"twenty":-9.666612,"median":-7.558062,"eighty":-1.2256,"marketCap":46799516},{"date":"2023-06-30","current":-1.488311,"twenty":-9.625615,"median":-7.541992,"eighty":-1.224177,"marketCap":49529488},{"date":"2023-07-07","current":-1.324245,"twenty":-9.59294,"median":-7.541173,"eighty":-1.224177,"marketCap":44069544},{"date":"2023-07-14","current":-1.324245,"twenty":-9.527072,"median":-7.523385,"eighty":-1.224177,"marketCap":44069544},{"date":"2023-07-21","current":-1.26565,"twenty":-9.498536,"median":-7.491871,"eighty":-1.224177,"marketCap":42119564},{"date":"2023-07-28","current":-1.195336,"twenty":-9.463887,"median":-7.460598,"eighty":-1.218774,"marketCap":39779588},{"date":"2023-08-04","current":-1.183617,"twenty":-9.434142,"median":-7.43501,"eighty":-1.207055,"marketCap":39389592},{"date":"2023-08-11","current":-1.160179,"twenty":-9.407958,"median":-7.3852,"eighty":-1.201289,"marketCap":38609601},{"date":"2023-08-18","current":-1.14846,"twenty":-9.407958,"median":-7.378691,"eighty":-1.195336,"marketCap":38219605},{"date":"2023-08-25","current":-1.089865,"twenty":-9.407958,"median":-7.362612,"eighty":-1.188832,"marketCap":36269625},{"date":"2023-09-01","current":-1.054708,"twenty":-9.407958,"median":-7.356852,"eighty":-1.183617,"marketCap":35099637},{"date":"2023-09-08","current":-1.078146,"twenty":-9.407958,"median":-7.342021,"eighty":-1.183617,"marketCap":35879629},{"date":"2023-09-15","current":-1.03127,"twenty":-9.34521,"median":-7.337925,"eighty":-1.171898,"marketCap":34319645},{"date":"2023-09-22","current":-0.972675,"twenty":-9.313335,"median":-7.297158,"eighty":-1.16457,"marketCap":32369665},{"date":"2023-09-29","current":-0.874822,"twenty":-9.240982,"median":-7.27836,"eighty":-1.151741,"marketCap":29113199},{"date":"2023-10-06","current":-0.91033,"twenty":-9.217485,"median":-7.259591,"eighty":-1.140308,"marketCap":30294886},{"date":"2023-10-13","current":-1.253931,"twenty":-9.205804,"median":-7.239403,"eighty":-1.1351,"marketCap":41729568},{"date":"2023-10-20","current":-1.218774,"twenty":-9.205804,"median":-7.235538,"eighty":-1.1351,"marketCap":40559580},{"date":"2023-10-27","current":-1.242212,"twenty":-9.209208,"median":-7.224676,"eighty":-1.13503,"marketCap":41339572},{"date":"2023-11-03","current":-1.078146,"twenty":-9.209208,"median":-7.208286,"eighty":-1.134538,"marketCap":35879629},{"date":"2023-11-10","current":-1.088107,"twenty":-9.209208,"median":-7.17486,"eighty":-1.125022,"marketCap":36211125},{"date":"2023-11-17","current":-1.094553,"twenty":-9.209208,"median":-7.14828,"eighty":-1.1144,"marketCap":36425623},{"date":"2023-11-24","current":-1.019551,"twenty":-9.147917,"median":-7.103719,"eighty":-1.109232,"marketCap":33929649},{"date":"2023-12-01","current":-1.001973,"twenty":-9.109429,"median":-7.053158,"eighty":-1.095491,"marketCap":33344655},{"date":"2023-12-08","current":-1.03127,"twenty":-9.097201,"median":-7.003635,"eighty":-1.088733,"marketCap":34319645},{"date":"2023-12-15","current":-1.089865,"twenty":-9.091899,"median":-6.948878,"eighty":-1.087152,"marketCap":36269625},{"date":"2023-12-22","current":-1.066427,"twenty":-9.091899,"median":-6.885419,"eighty":-1.081608,"marketCap":35489633},{"date":"2023-12-29","current":-1.028927,"twenty":-9.093583,"median":-6.875377,"eighty":-1.078076,"marketCap":34241646},{"date":"2024-01-05","current":-1.054708,"twenty":-9.095268,"median":-6.858339,"eighty":-1.077926,"marketCap":35099637},{"date":"2024-01-12","current":-0.996349,"twenty":-9.095268,"median":-6.840522,"eighty":-1.074265,"marketCap":33157496},{"date":"2024-01-19","current":-1.054708,"twenty":-9.096952,"median":-6.803887,"eighty":-1.066427,"marketCap":35099637},{"date":"2024-01-26","current":-1.043106,"twenty":-9.095268,"median":-6.79162,"eighty":-1.061982,"marketCap":34713541},{"date":"2024-02-02","current":-1.171898,"twenty":-9.095268,"median":-6.751703,"eighty":-1.061982,"marketCap":38999597},{"date":"2024-02-09","current":-1.623872,"twenty":-9.095268,"median":-6.670796,"eighty":-1.061982,"marketCap":44672720},{"date":"2024-02-16","current":-1.942974,"twenty":-9.095268,"median":-6.639575,"eighty":-1.061982,"marketCap":53451202},{"date":"2024-02-23","current":-1.517505,"twenty":-9.095268,"median":-6.607596,"eighty":-1.061982,"marketCap":41746559},{"date":"2024-03-01","current":-1.886244,"twenty":-9.093583,"median":-6.55367,"eighty":-1.062507,"marketCap":51890583},{"date":"2024-03-08","current":-4.21214,"twenty":-9.093583,"median":-6.502965,"eighty":-1.062507,"marketCap":115875963},{"date":"2024-03-15","current":-4.112864,"twenty":-9.093583,"median":-6.458528,"eighty":-1.062507,"marketCap":113144880},{"date":"2024-03-22","current":-4.226322,"twenty":-9.093583,"median":-6.420725,"eighty":-1.062507,"marketCap":116266118},{"date":"2024-03-28","current":-5.148171,"twenty":-9.093583,"median":-6.400805,"eighty":-1.062507,"marketCap":141626177},{"date":"2024-04-05","current":-3.687395,"twenty":-9.095268,"median":-6.347041,"eighty":-1.061982,"marketCap":101440237},{"date":"2024-04-12","current":-2.921551,"twenty":-9.095268,"median":-6.303807,"eighty":-1.061982,"marketCap":80371880},{"date":"2024-04-19","current":-2.552812,"twenty":-9.095268,"median":-6.283707,"eighty":-1.061982,"marketCap":70227856},{"date":"2024-04-26","current":-3.219379,"twenty":-9.093583,"median":-6.26634,"eighty":-1.062507,"marketCap":88565130},{"date":"2024-05-03","current":-3.063516,"twenty":-9.093583,"median":-6.253291,"eighty":-1.062507,"marketCap":84277329},{"date":"2024-05-10","current":-3.304473,"twenty":-9.093583,"median":-6.253291,"eighty":-1.062507,"marketCap":90906059},{"date":"2024-05-17","current":-4.022089,"twenty":-9.093583,"median":-6.162033,"eighty":-1.062507,"marketCap":110647677},{"date":"2024-05-24","current":-6.36688,"twenty":-9.093583,"median":-6.150673,"eighty":-1.062507,"marketCap":133870029},{"date":"2024-05-31","current":-4.881894,"twenty":-9.093583,"median":-6.111473,"eighty":-1.062507,"marketCap":102646698},{"date":"2024-06-07","current":-4.529209,"twenty":-9.093583,"median":-5.991392,"eighty":-1.062507,"marketCap":95231157},{"date":"2024-06-14","current":-4.900456,"twenty":-9.093583,"median":-5.119806,"eighty":-1.062507,"marketCap":103036990},{"date":"2024-06-21","current":-4.69627,"twenty":-9.065467,"median":-5.074578,"eighty":-1.061982,"marketCap":98743782},{"date":"2024-06-28","current":-4.45496,"twenty":-9.049757,"median":-4.938699,"eighty":-1.061982,"marketCap":93669991},{"date":"2024-07-05","current":-4.547772,"twenty":-9.034297,"median":-4.866118,"eighty":-1.061982,"marketCap":95621449},{"date":"2024-07-12","current":-4.343586,"twenty":-9.027495,"median":-4.646187,"eighty":-1.061982,"marketCap":91328241},{"date":"2024-07-19","current":-4.083713,"twenty":-9.008296,"median":-4.566515,"eighty":-1.061982,"marketCap":85864158},{"date":"2024-07-26","current":-3.647499,"twenty":-9.008296,"median":-4.482804,"eighty":-1.061982,"marketCap":76692305},{"date":"2024-08-02","current":-3.434032,"twenty":-9.005363,"median":-4.402793,"eighty":-1.061982,"marketCap":72203951},{"date":"2024-08-09","current":-3.601093,"twenty":-8.998216,"median":-4.325024,"eighty":-1.061982,"marketCap":75716576},{"date":"2024-08-16","current":-3.471156,"twenty":-8.984285,"median":-4.268869,"eighty":-1.061982,"marketCap":72984534},{"date":"2024-08-23","current":-3.563968,"twenty":-8.966097,"median":-4.219986,"eighty":-1.061982,"marketCap":74935992},{"date":"2024-08-30","current":-5.280878,"twenty":-8.938391,"median":-4.194332,"eighty":-1.061982,"marketCap":82212714},{"date":"2024-09-06","current":-5.099672,"twenty":-8.913084,"median":-4.194332,"eighty":-1.061982,"marketCap":79391689},{"date":"2024-09-13","current":-5.953931,"twenty":-8.88535,"median":-4.194332,"eighty":-1.061982,"marketCap":92690805},{"date":"2024-09-20","current":-5.513858,"twenty":-8.862512,"median":-4.194332,"eighty":-1.061982,"marketCap":85839745},{"date":"2024-09-27","current":-5.695065,"twenty":-8.83563,"median":-4.194332,"eighty":-1.061982,"marketCap":88660770},{"date":"2024-10-04","current":-6.135138,"twenty":-8.820265,"median":-4.194332,"eighty":-1.061982,"marketCap":95511829},{"date":"2024-10-11","current":-6.445778,"twenty":-8.804634,"median":-4.194332,"eighty":-1.061982,"marketCap":100347871},{"date":"2024-10-18","current":-6.057478,"twenty":-8.774324,"median":-4.194332,"eighty":-1.061982,"marketCap":94302819},{"date":"2024-10-25","current":-5.850385,"twenty":-8.734517,"median":-4.194332,"eighty":-1.061982,"marketCap":91078791},{"date":"2024-11-01","current":-5.772725,"twenty":-8.734517,"median":-4.194332,"eighty":-1.061982,"marketCap":89869780},{"date":"2024-11-08","current":-5.022012,"twenty":-8.734517,"median":-4.194332,"eighty":-1.061982,"marketCap":78182679},{"date":"2024-11-15","current":-4.193639,"twenty":-8.734517,"median":-4.185082,"eighty":-1.061982,"marketCap":65286567},{"date":"2024-11-22","current":-4.504279,"twenty":-8.725745,"median":-4.185082,"eighty":-1.061982,"marketCap":70122609},{"date":"2024-11-29","current":-4.996125,"twenty":-8.713034,"median":-4.185082,"eighty":-1.061982,"marketCap":77779675},{"date":"2024-12-06","current":-4.400732,"twenty":-8.69392,"median":-4.185082,"eighty":-1.061982,"marketCap":68510595},{"date":"2024-12-13","current":-4.245412,"twenty":-8.668422,"median":-4.173059,"eighty":-1.061982,"marketCap":66092574},{"date":"2024-12-20","current":-4.115979,"twenty":-8.623519,"median":-4.114422,"eighty":-1.061982,"marketCap":64077556},{"date":"2024-12-27","current":-4.180695,"twenty":-8.596523,"median":-4.114422,"eighty":-1.061982,"marketCap":65085065},{"date":"2025-01-03","current":-4.219525,"twenty":-8.568166,"median":-4.114422,"eighty":-1.061982,"marketCap":65689570},{"date":"2025-01-10","current":-4.297185,"twenty":-8.543875,"median":-4.112864,"eighty":-1.061457,"marketCap":66898581},{"date":"2025-01-17","current":-4.452505,"twenty":-8.475638,"median":-4.112864,"eighty":-1.061457,"marketCap":69316602},{"date":"2025-01-24","current":-4.426619,"twenty":-8.440174,"median":-4.112864,"eighty":-1.061457,"marketCap":68913598},{"date":"2025-01-31","current":-4.633712,"twenty":-8.413839,"median":-4.112864,"eighty":-1.061457,"marketCap":72137626},{"date":"2025-02-07","current":-4.323072,"twenty":-8.379544,"median":-4.112864,"eighty":-1.061457,"marketCap":67301584},{"date":"2025-02-14","current":-4.426877,"twenty":-8.325638,"median":-4.112864,"eighty":-1.061457,"marketCap":68917628},{"date":"2025-02-21","current":-4.633712,"twenty":-8.280104,"median":-4.112864,"eighty":-1.061457,"marketCap":72137626},{"date":"2025-02-28","current":-4.374845,"twenty":-8.216736,"median":-4.112864,"eighty":-1.061457,"marketCap":68107591},{"date":"2025-03-07","current":-4.323072,"twenty":-8.165465,"median":-4.112864,"eighty":-1.06142,"marketCap":67301584},{"date":"2025-03-14","current":-4.505832,"twenty":-8.144499,"median":-4.112864,"eighty":-1.06142,"marketCap":70146789},{"date":"2025-03-21","current":-4.141865,"twenty":-8.099624,"median":-4.112864,"eighty":-1.06142,"marketCap":64480560},{"date":"2025-03-28","current":-5.21941,"twenty":-8.029949,"median":-4.052901,"eighty":-1.06142,"marketCap":58055500},{"date":"2025-04-04","current":-4.856951,"twenty":-7.975726,"median":-4.052901,"eighty":-1.06142,"marketCap":54023868},{"date":"2025-04-11","current":-3.98705,"twenty":-7.904381,"median":-4.017609,"eighty":-1.061457,"marketCap":44347952},{"date":"2025-04-17","current":-4.748214,"twenty":-7.829624,"median":-4.017609,"eighty":-1.061457,"marketCap":52814379},{"date":"2025-04-25","current":-5.799345,"twenty":-7.762945,"median":-4.016303,"eighty":-1.06142,"marketCap":64506112},{"date":"2025-05-02","current":-6.125558,"twenty":-7.734259,"median":-4.016303,"eighty":-1.06142,"marketCap":68134580},{"date":"2025-05-09","current":-6.089312,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":67731417},{"date":"2025-05-16","current":-19.597391,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":66925091},{"date":"2025-05-23","current":-19.833504,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":67731417},{"date":"2025-05-30","current":-20.561913,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":70218934},{"date":"2025-06-06","current":-19.833504,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":67731417},{"date":"2025-06-13","current":-33.41001,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":114095185},{"date":"2025-06-20","current":-36.715594,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":125383755},{"date":"2025-06-27","current":-29.750257,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":101597126},{"date":"2025-07-03","current":-26.326616,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":89905393},{"date":"2025-07-11","current":-26.562729,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":90711720},{"date":"2025-07-18","current":-25.972446,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":88695904},{"date":"2025-07-25","current":-23.021032,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":78616824},{"date":"2025-08-01","current":-24.201598,"twenty":-7.735622,"median":-4.014996,"eighty":-1.061383,"marketCap":82648456},{"date":"2025-08-08","current":-24.087125,"twenty":-7.765539,"median":-4.014996,"eighty":-1.061383,"marketCap":82257532},{"date":"2025-08-15","current":-68.124339,"twenty":-7.829624,"median":-4.014996,"eighty":-1.061383,"marketCap":81067963},{"date":"2025-08-22","current":-59.651162,"twenty":-7.867699,"median":-4.014996,"eighty":-1.061383,"marketCap":70984883},{"date":"2025-08-29","current":-61.006871,"twenty":-7.942625,"median":-4.014996,"eighty":-1.061383,"marketCap":72598176},{"date":"2025-09-05","current":-62.362578,"twenty":-8.008083,"median":-4.013714,"eighty":-1.061345,"marketCap":74211468},{"date":"2025-09-12","current":-63.37936,"twenty":-8.051793,"median":-4.014996,"eighty":-1.061383,"marketCap":75421438},{"date":"2025-09-19","current":-58.295454,"twenty":-8.051793,"median":-4.014996,"eighty":-1.061383,"marketCap":69371590},{"date":"2025-09-26","current":-56.939745,"twenty":-8.138933,"median":-4.014996,"eighty":-1.061383,"marketCap":67758297},{"date":"2025-10-03","current":-58.634381,"twenty":-8.238495,"median":-4.014996,"eighty":-1.061383,"marketCap":69774913},{"date":"2025-10-10","current":-61.345797,"twenty":-8.238495,"median":-4.014996,"eighty":-1.061383,"marketCap":73001499},{"date":"2025-10-17","current":-60.49848,"twenty":-8.238495,"median":-4.014996,"eighty":-1.061383,"marketCap":71993191},{"date":"2025-10-24","current":-68.463266,"twenty":-8.295661,"median":-4.014996,"eighty":-1.061383,"marketCap":81471286},{"date":"2025-10-31","current":-64.735068,"twenty":-8.295661,"median":-4.014996,"eighty":-1.061383,"marketCap":77034731},{"date":"2025-11-07","current":-65.073995,"twenty":-8.317462,"median":-4.014996,"eighty":-1.061383,"marketCap":77438054},{"date":"2025-11-14","current":-69.818974,"twenty":-8.317462,"median":-4.014996,"eighty":-1.061383,"marketCap":83084579},{"date":"2025-11-21","current":-117.35491,"twenty":-8.403551,"median":-4.014996,"eighty":-1.061383,"marketCap":70178236},{"date":"2025-11-28","current":-145.784813,"twenty":-8.440594,"median":-4.014996,"eighty":-1.061383,"marketCap":87179318},{"date":"2025-12-05","current":-132.719192,"twenty":-8.503786,"median":-4.014996,"eighty":-1.061383,"marketCap":79366077},{"date":"2025-12-12","current":-149.910798,"twenty":-8.562452,"median":-4.014996,"eighty":-1.061383,"marketCap":89646657},{"date":"2025-12-19","current":-128.593207,"twenty":-8.61847,"median":-4.014996,"eighty":-1.061383,"marketCap":76898738},{"date":"2025-12-26","current":-132.031528,"twenty":-8.683631,"median":-4.014996,"eighty":-1.061383,"marketCap":78954854},{"date":"2026-01-02","current":-112.089266,"twenty":-8.713986,"median":-4.014996,"eighty":-1.061383,"marketCap":67029381},{"date":"2026-01-09","current":-109.338609,"twenty":-8.744078,"median":-4.014996,"eighty":-1.061383,"marketCap":65384488},{"date":"2026-01-16","current":-121.716565,"twenty":-8.744078,"median":-4.014996,"eighty":-1.061383,"marketCap":72786506},{"date":"2026-01-23","current":-114.839923,"twenty":-8.776229,"median":-4.014996,"eighty":-1.061383,"marketCap":68674274},{"date":"2026-01-30","current":-107.275617,"twenty":-8.801379,"median":-4.014996,"eighty":-1.061383,"marketCap":64150819},{"date":"2026-02-06","current":-105.900288,"twenty":-8.824243,"median":-4.014996,"eighty":-1.061383,"marketCap":63328372},{"date":"2026-02-13","current":-94.209997,"twenty":-8.824243,"median":-4.014996,"eighty":-1.061383,"marketCap":56337578},{"date":"2026-02-20","current":-90.771676,"twenty":-8.824243,"median":-4.014996,"eighty":-1.061383,"marketCap":54281462},{"date":"2026-02-27","current":-89.396348,"twenty":-8.847106,"median":-4.014996,"eighty":-1.061383,"marketCap":53459016},{"date":"2026-03-06","current":-102.461967,"twenty":-8.978573,"median":-4.014996,"eighty":-1.061383,"marketCap":61272256},{"date":"2026-03-13","current":-112.089266,"twenty":-9.171771,"median":-4.014996,"eighty":-1.061383,"marketCap":67029381},{"date":"2026-03-20","current":-107.275617,"twenty":-9.560454,"median":-4.014996,"eighty":-1.061383,"marketCap":64150819},{"date":"2026-03-27","current":-65.812063,"twenty":-12.877976,"median":-4.014996,"eighty":-1.061383,"marketCap":66206935},{"date":"2026-04-02","current":-69.895519,"twenty":-13.201682,"median":-4.014996,"eighty":-1.061383,"marketCap":70314892},{"date":"2026-04-10","current":-72.347993,"twenty":-13.956876,"median":-4.014996,"eighty":-1.061383,"marketCap":72782081},{"date":"2026-04-17","current":-68.669281,"twenty":-14.862192,"median":-4.014996,"eighty":-1.061383,"marketCap":69081297},{"date":"2026-04-24","current":-67.85179,"twenty":-16.29052,"median":-4.014996,"eighty":-1.061383,"marketCap":68258901},{"date":"2026-05-01","current":-62.137525,"twenty":-17.553263,"median":-4.014996,"eighty":-1.061383,"marketCap":62510350}],"updateTime":1777803143299},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BYSI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629076662","title":"BeyondSpring publishes corporate presentation on plinabulin immune-modulating cancer therapy pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2629076662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629076662?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:07","pubTimestamp":1776895622,"startTime":"0","endTime":"0","summary":"BeyondSpring investor deck highlighted plinabulin as lead late-stage asset, positioning it as a first-in-class, reversible tubulin depolymerizing agent with immune-modulating activity.DUBLIN-3 Phase 3 trial in 2L/3L NSCLC EGFR wild type reported overall survival benefit for plinabulin + docetaxel vs docetaxel, with OS HR 0.82.Study showed median OS 10.5 months for plinabulin + docetaxel vs 9.4 months for docetaxel.Safety readout cited grade 4 neutropenia reduction on day 8 across all cycles, with 22.3% on plinabulin + docetaxel vs 43.5% on docetaxel.Pipeline update flagged SEED targeted protein degradation platform, with lead oral RBM39 degrader entering Phase 1.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. publishe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL65Gq5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010045","title":"BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010045","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010045?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":"New Preclinical Results at AACR 2026 Show Plinabulin Dramatically Improves Complete Response Rates and Survival When Combined with Leading ADC Drugs— With or Without Immunotherapy Plinabulin’s GEF-H1 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/22/3278803/0/en/BeyondSpring-Reports-Compelling-New-Data-Plinabulin-Advances-Both-the-Anticancer-Efficacy-and-Safety-of-ADC-Drugs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4080","BYSI","BK4139","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623174314","title":"BeyondSpring to present plinabulin-ADC combination data at AACR annual meeting poster session","url":"https://stock-news.laohu8.com/highlight/detail?id=2623174314","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623174314?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:31","pubTimestamp":1774870279,"startTime":"0","endTime":"0","summary":"BeyondSpring to present poster on plinabulin with antibody-drug conjugates at AACR Annual Meeting, held April 17-22, 2026 in San Diego.Poster presentation scheduled April 21, 2026 from 2 p.m. to 5 p.m. PT at San Diego Convention Center.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL8xdj2J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00B64PRP62.GBP","BK4585","BYSI","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","SG9999014013.SGD","NDAQ","SG9999014039.USD","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","LU2095319765.USD","BK4139","IE00BN0W2T93.GBP","BK4112","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623129133","title":"BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2623129133","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623129133?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:30","pubTimestamp":1774870200,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., March  30, 2026 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage company developing transformative therapies for the treatme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/30/3264525/0/en/BeyondSpring-Announces-Plinabulin-and-ADC-Combination-Poster-Presentation-at-AACR-Annual-Meeting-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADC","BYSI","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622738863","title":"BeyondSpring publishes IO360 Summit presentation on plinabulin; PD-1/L1 resistance highlighted","url":"https://stock-news.laohu8.com/highlight/detail?id=2622738863","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622738863?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:37","pubTimestamp":1774532272,"startTime":"0","endTime":"0","summary":"BeyondSpring published a presentation titled “Overcoming PD-1/L1 Resistance: Translational Insights with Plinabulin.”The presentation was posted as part of the 2026 IO360 Summit materials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to generate this news brief on March 25, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL4FjxmF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622569858","title":"BeyondSpring publishes corporate presentation; plinabulin clinical program advances and SEED targeted protein degradation pipeline grows","url":"https://stock-news.laohu8.com/highlight/detail?id=2622569858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622569858?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:21","pubTimestamp":1774520481,"startTime":"0","endTime":"0","summary":"BeyondSpring publishes corporate presentation; plinabulin clinical program advances and SEED targeted protein degradation pipeline grows. BeyondSpring outlined development plans for plinabulin, a small-molecule immune modulator positioned for use with docetaxel in later-line non-small cell lung cancer .In the global Phase 3 DUBLIN-3 study , plinabulin plus docetaxel reported median overall survival of 10.5 months versus 9.4 months for docetaxel, with a hazard ratio of 0.82.The presentation reported grade 4 neutropenia rates of 5.13% with plinabulin plus docetaxel versus 33.58% with docetaxel.BeyondSpring said the planned DUBLIN-4 confirmatory Phase 3 study will evaluate plinabulin plus docetaxel versus docetaxel in 2L/3L non-squamous NSCLC after PD-1/L1 progression, with a progression-free survival threshold of at least 3 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely inf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL48394s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622300212","title":"BeyondSpring FY2025 net loss drops 15% to $14 million; research and development expenses climb 66% to $4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622300212","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622300212?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:37","pubTimestamp":1774471045,"startTime":"0","endTime":"0","summary":"BeyondSpring published its annual report on Form 10-K for the fiscal year ended Dec. 31, 2025.Net loss was USD 14.2 million, compared with a 15% narrower loss year over year.R&D expense rose 66% to USD 4.4 million, driven by expanded drug manufacturing activities, increased NSCLC data management efforts, higher combination-therapy research to support partnering, higher regulatory professional services, and higher personnel costs.G&A expense fell 25% to USD 4.6 million, reflecting lower personnel costs from reduced headcount, lower business development and partnership consulting, and reduced corporate overhead including D&O insurance and investor marketing advisory expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring In","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL9sJKct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622110888","title":"BeyondSpring Files 2025 Annual Report on Form 10-K","url":"https://stock-news.laohu8.com/highlight/detail?id=2622110888","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622110888?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:30","pubTimestamp":1774470600,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., March  25, 2026 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage company developing transformative therapies for the treatme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/25/3262607/0/en/BeyondSpring-Files-2025-Annual-Report-on-Form-10-K.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075254","title":"BeyondSpring Q4 EPS $(0.05)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075254","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075254?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:35","pubTimestamp":1774442134,"startTime":"0","endTime":"0","summary":"BeyondSpring (NASDAQ:BYSI) reported quarterly losses of $(0.05) per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51453963/beyondspring-q4-eps-0-05","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622307548","title":"BeyondSpring FY2025 operating loss narrows 2.25% to $8.7 million; R&D expenses jump 69.23% to $4.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622307548","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622307548?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:31","pubTimestamp":1774441898,"startTime":"0","endTime":"0","summary":"R&D expenses jumped 69.23% to $4.4 million on higher drug manufacturing, NSCLC data management, Plinabulin combination research, regulatory consulting, and personnel costs.G&A expenses fell 24.59% to $4.6 million on lower personnel costs, reduced consulting expenses, and lower corporate overhead.Cash, cash equivalents, and short-term investments totaled $12.6 million.Chief Executive Officer Lan Huang said the company remained focused on advancing the DUBLIN-4 confirmatory trial for Plinabulin in EGFR wild-type non-squamous NSCLC post immune checkpoint inhibitors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Anal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL7HRC0m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075136","title":"Beyondspring Reports 2025 Year-End Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075136","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075136?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:30","pubTimestamp":1774441802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nTUA90MXY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622107545","title":"Press Release: BeyondSpring Reports 2025 Year-End Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622107545","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622107545?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:30","pubTimestamp":1774441800,"startTime":"0","endTime":"0","summary":"-- Phase 3 Survival Benefit Confirmed: Plinabulin combined with docetaxel. standard of care docetaxel in EGFR wild-type NSCLC patients whose tumors. progressed after first line therapy -- DUBLIN-3 study results published. discussions, BeyondSpring is advancing DUBLIN-4, a confirmatory global. Phase 3 study in a biomarker-selected EGFR wild-type NSCLC patient. sensitivity to checkpoint inhibitors -- a significant unmet need. Cell Press journal Med 2025 and presented at SITC 2025. \"2025 was a year of important clinical and operational progress for BeyondSpring and SEED Therapeutics,\" said Dr. Lan Huang, Co-Founder, Chairman and Chief Executive Officer of BeyondSpring. \"We advanced our Phase 3 Plinabulin program, generated meaningful clinical data, and strengthened our strategic and financial position.\". \"BeyondSpring made meaningful progress advancing Plinabulin in Phase 3 NSCLC, while SEED Therapeutics reached a critical milestone -- initiating its first clinical trial following IND cle","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","HR","ORR","BK4139","BK4225","BK4203","BK4195","BYSI","BK4211","PFS","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610377466","title":"BeyondSpring Showcases Plinabulin at Immuno-Oncology 360° Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2610377466","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610377466?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:15","pubTimestamp":1770639311,"startTime":"0","endTime":"0","summary":"BeyondSpring Inc. , a clinical-stage biopharmaceutical company specializing in immune-modulating cancer therapies, will participate in the Immuno-Oncology 360°  Conference 2026, scheduled for February 10-12, 2026, in Boston, MA. Dr. Lan Huang, Co-Founder, Chairman, and CEO of BeyondSpring, will deliver a presentation titled “Overcoming PD-1/L1 Resistance: Translational Insights with Plinabulin” on Wednesday, February 11, 2026, from 4:55PM to 5:10PM ET at the Sheraton Boston Hotel, Track 1, Grand Ballroom. Following the presentation, the slides will be available on the \"Posters and Presentations\" page of BeyondSpring's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to genera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL9ccQCl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","NDAQ","BK4585","SG9999014005.SGD","LU0314104364.USD","SG9999014039.USD","SG9999014021.USD","BK4139","BK4112","IE00BKPKM429.USD","BYSI","IE00BGHQF748.EUR","LU2210150020.SGD","LU2095319765.USD","BK4588","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591624439","title":"BeyondSpring Sells $35.4 Million Stake in SEED Therapeutics to Strategic Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2591624439","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591624439?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:30","pubTimestamp":1765834258,"startTime":"0","endTime":"0","summary":"BeyondSpring Inc. has entered into a series of Preferred Share Purchase Agreements to sell a total of 8,333,637 Series A-1 Preferred Shares of SEED Therapeutics Inc. for an aggregate purchase price of approximately $35.4 million, pricing the shares at $4.25 each. Under these agreements, Winning View Investment Limited will acquire 1,436,327 shares, FULL TECH CORPORATE DEVELOPMENT LIMITED will purchase 555,576 shares, and Mapfil Investment Limited will buy 1,111,152 shares, all no later than December 15, 2025. The closings of these transactions are currently expected to be completed in the first half of 2026, though the timeline may be subject to further delays.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDLSsvkS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590061895","title":"BeyondSpring Shares Shares Jump Premarket Following Positive Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2590061895","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590061895?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:38","pubTimestamp":1765543080,"startTime":"0","endTime":"0","summary":"BeyondSpring's shares rallied ahead of the opening bell after the biopharmaceutical company reported positive results among an Asian subset in a late-stage trial of its lung cancer treatment.In Friday's premarket trading, the shares were 16% higher. The stock closed the previous session at $2.18, up 34% in 2025.BeyondSpring said results from a large Asian cohort in its global Phase 3 study evaluating Plinabulin plus docetaxel in second- or third-line epidermal growth factor receptor wild-type non-small cell lung cancer showed a statistically significant improvement in overall survival compared with docetaxel alone.The findings highlight an enhanced benefit in patients whose disease biology aligns with Plinabulin's immune-modulating and tumor vasculature-targeting mechanisms, the company said. It added that the combination also doubled two-year and three-year survival rates.Plinabulin, a brain-penetrating, dendritic-cell maturation small molecule, demonstrated a marked reduction in doce","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"BeyondSpring Shares Shares Jump Premarket Following Positive Trial Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590750529","title":"BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path","url":"https://stock-news.laohu8.com/highlight/detail?id=2590750529","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590750529?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:00","pubTimestamp":1765540800,"startTime":"0","endTime":"0","summary":"Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin as a late-stage candidate showing survival improvement ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/12/3204554/0/en/BeyondSpring-Announces-ESMO-Asia-Presentation-on-Plinabulin-Docetaxel-Improving-Survival-in-Large-Phase-3-DUBLIN-3-Asian-Subset-for-EGFR-WT-NSCLC-Compared-to-Docetaxel-Strengthenin.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","BYSI","BK4135","LU0053671581.USD","WT","ITT","IE00BHPRN162.USD","LU0054578231.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590518274","title":"BeyondSpring Reports Plinabulin Plus Docetaxel Improves Survival in EGFR Wild-Type NSCLC After Checkpoint Inhibitor Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2590518274","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590518274?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:02","pubTimestamp":1765454522,"startTime":"0","endTime":"0","summary":"BeyondSpring Inc. announced new post-hoc analyses from its global Phase 3 DUBLIN-3 Study, evaluating Plinabulin in combination with docetaxel for patients with EGFR wild-type non-squamous non-small cell lung cancer  who have progressed after anti-PD-1 immunotherapy. The results, presented at the 2025 IASLC/ASCO North America Conference on Lung Cancer , showed that the combination of Plinabulin and docetaxel provided clinically meaningful improvements in overall survival, progression-free survival, and objective response rate compared to docetaxel alone. Specifically, median overall survival was 15.8 months for the combination versus 11.7 months for docetaxel alone, with a hazard ratio of 0.55. Median progression-free survival was 5.6 months versus 3.8 months , and the objective response rate was 18.2% versus 8.0%. The company also reported reductions in brain metastasis and a substantial improvement in metastasis-free survival. BeyondSpring plans to initiate the global Phase 3 DUBLIN-4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL1qwhfK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","NDAQ","BK4585","SG9999014005.SGD","LU0314104364.USD","SG9999014039.USD","SG9999014021.USD","BK4139","BK4112","IE00BKPKM429.USD","BYSI","IE00BGHQF748.EUR","LU2210150020.SGD","LU2095319765.USD","BK4588","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590518191","title":"Beyondspring Announces New Analyses of Dublin-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-Pd-(L)1 for Non-Squamous Egfr Wt Nsclc and a Reduction in Brain Metastasis Compared to Docetaxel at Naclc 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2590518191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590518191?lang=en_us&edition=fundamental","pubTime":"2025-12-11 20:00","pubTimestamp":1765454402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA6JTZ0J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582237554","title":"BeyondSpring Q3 EPS $(0.04) Up From $(0.05) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2582237554","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582237554?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:12","pubTimestamp":1762949545,"startTime":"0","endTime":"0","summary":"BeyondSpring (NASDAQ:BYSI) reported quarterly losses of $(0.04) per share. This is a 20 percent increase over losses of $(0.05) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48799213/beyondspring-q3-eps-0-04-up-from-0-05-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","BYSI","TSYW.SI","BK4139","SQQQ","QLD","TQQQ","USJW.SI","QID","NVIW.SI","USAW.SI",".IXIC","NQmain","PSQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582758003","title":"Drugmaker BeyondSpring's Q3 net loss narrows to $1.7 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2582758003","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582758003?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:08","pubTimestamp":1762949330,"startTime":"0","endTime":"0","summary":"Drugmaker BeyondSpring's Q3 net loss narrows to $1.7 mlnOverviewBeyondSpring Q3 net loss narrows to $1.7 mln from $2.2 mln last yearPlinabulin shows promising results in NSCLC patients at SITC 2025 pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}